Clinical Trials
36 trialsT-DIS
Centre Oscar Lambret
PIPER
Institut Bergonié
A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas
M.D. Anderson Cancer Center
TRABEPIO
Mario Negri Institute for Pharmacological Research
U01CA236220
Sarcoma Alliance for Research through Collaboration
Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma
University of Michigan Rogel Cancer Center
TRABTRAP
Universität Münster
L-UteCIN
UNICANCER
COMPASS
North Eastern German Society of Gynaecological Oncology
SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma
Sarcoma Oncology Research Center, LLC
TNT
Sarcoma Oncology Research Center, LLC
TAGGED
Sarcoma Oncology Research Center, LLC
NCT-PMO-1603
National Center for Tumor Diseases, Heidelberg
Trabectedin and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Resistant or Intolerant to a BTK Inhibitor
M.D. Anderson Cancer Center
TRASTS
Grupo Espanol de Investigacion en Sarcomas
OLATRASTS
Grupo Espanol de Investigacion en Sarcomas
SYNERGIAS
Grupo Espanol de Investigacion en Sarcomas
HyperTET
Ludwig-Maximilians - University of Munich
NiTraSarc
University Medicine Greifswald
Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery
Fred Hutchinson Cancer Center
INOVATYON
Mario Negri Institute for Pharmacological Research
MITO23
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
MITO 26
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
ATREUS
Mario Negri Institute for Pharmacological Research
Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer
Mario Negri Institute for Pharmacological Research
Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma
Fred Hutchinson Cancer Center
Trabectedin, Doxorubicin and Olaratumab in Patients With Metastatic or Recurrent Leiomyosarcoma
University of Miami
Assessing the Combination of Durvalumab (MEDI4736) and Trabectedin in Solid Tumors
University of Colorado, Denver
TSAR
Gustave Roussy, Cancer Campus, Grand Paris
TAUL
Mario Negri Institute for Pharmacological Research
Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS
Grupo Espanol de Investigacion en Sarcomas
Combination Therapy of Gemcitabine and Trabectedin in L-sarcomas
Heidelberg University
PACT-18
IRCCS San Raffaele
Ecteinascidin 743 in Treating Patients With Previously Treated Metastatic Osteosarcoma
Memorial Sloan Kettering Cancer Center
MITO15
Catholic University of the Sacred Heart
ET 743 (Yondelis) in Men With Advanced Prostate Cancer
Massachusetts General Hospital